Albert Christian Petersen

Title: Albert Christian Petersen: Innovator in Pharmaceutical Chemistry

Introduction

Albert Christian Petersen is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing gastrointestinal disorders, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Petersen holds a patent for "Macrocyclic 13-membered ring derivatives of erythromycins A and B." This patent describes novel macrocyclic 13-membered ring-contracted compounds derived from erythromycins A and B. These compounds, along with their pharmaceutically acceptable salts, are specifically defined and have applications in treating gastrointestinal disorders associated with hypermotilinemia. The patent also outlines pharmaceutical compositions, methods of treatment, and processes for preparation.

Career Highlights

Throughout his career, Petersen has been associated with Abbott Laboratories Corporation, a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic solutions. His innovative approach has positioned him as a valuable asset in the field.

Collaborations

Petersen has collaborated with notable colleagues, including Hugh Nerby Nellans and Cynthia Burnell Curty. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Albert Christian Petersen's contributions to pharmaceutical chemistry, particularly through his patent on macrocyclic compounds, highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the field and offers promising solutions for gastrointestinal disorders.